Inhibition of Uqcrfs1 can suppress the abnormal proliferation of PASMCs by inhibiting ROS and ERS
This study demonstrates that inhibiting Uqcrfs1 suppresses abnormal pulmonary artery smooth muscle cell proliferation and alleviates chronic hypoxia-induced pulmonary hypertension by reducing mitochondrial reactive oxygen species and endoplasmic reticulum stress, thereby validating Uqcrfs1 as a promising therapeutic target.